Hypoxia Induced Multidrug Resistance of Laryngeal Cancer Cells via Hypoxia-inducible Factor-1α

  • Li, Da-Wei (Department of Otolaryngology-Head and Neck Surgery, Affiliated Eye and ENT Hospital of Fudan University) ;
  • Dong, Pin (Department of Otolaryngology-Head and Neck Surgery, Shanghai Jiaotong University Affiliated First People's Hospital) ;
  • Wang, Fei (Department of Otolaryngology-Head and Neck Surgery, Shanghai Jiaotong University Affiliated First People's Hospital) ;
  • Chen, Xin-Wei (Department of Otolaryngology-Head and Neck Surgery, Shanghai Jiaotong University Affiliated First People's Hospital) ;
  • Xu, Cheng-Zhi (Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine) ;
  • Zhou, Liang (Department of Otolaryngology-Head and Neck Surgery, Affiliated Eye and ENT Hospital of Fudan University)
  • Published : 2013.08.30


Objectives: To investigate whether hypoxia has an effect on regulation of multidrug resistance (MDR) to chemotherapeutic drugs in laryngeal carcinoma cells and explore the role of hypoxia-inducible factor-$1{\alpha}$ (HIF-$1{\alpha}$). Methods: Laryngeal cancer cells were cultured under normoxic and hypoxic conditions. The sensitivity of the cells to multiple drugs and levels of apoptosis induced by paclitaxel were determined by MTT assay and annexin-V/propidium iodide staining analysis, respectively. HIF-$1{\alpha}$ expression was blocked by RNA interference. The expression of HIF-$1{\alpha}$ gene was detected by real-time quantitative RT-PCR and Western blotting. The value of fluorescence intensity of intracellular adriamycin accumulation and retention in cells was evaluated by flow cytometry. Results: The sensitivity to multiple chemotherapy agents and induction of apoptosis by paclitaxel could be reduced by hypoxia (P<0.05). A the same time, the adriamycin releasing index of cells was increased (P<0.05). However, resistance acquisition subject to hypoxia in vitro was suppressed by down-regulating HIF-$1{\alpha}$ expression. Conclusion: HIF-$1{\alpha}$ could be considered as a key regulator for mediating hypoxia-induced MDR in laryngeal cancer cells via inhibition of drug-induced apoptosis and decrease in intracellular drug accumulation.


Cell hypoxia;hypoxia inducible factor-$1{\alpha}$;drug resistance, multiple;laryngeal neoplasms


  1. Chou CW, Wang CC, Wu CP, et al (2012). Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1. Neuro Oncol, 14, 1227-38.
  2. Chu EA, Kim YJ (2008). Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am, 41, 673-95.
  3. Huang L, Ao Q, Zhang Q, et al (2010). Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. J Cancer Res Clin Oncol, 136, 447-56.
  4. Huang S, Peng L, Tang Y, et al (2013). Hypoxia of PC-3 prostate cancer cells enhances migration and vasculogenesis in vitro of bone marrow-derived endothelial progenitor cells by secretion of cytokines. Oncol Rep, 29, 2369-77.
  5. Jing SW, Wang YD, Kuroda M, et al (2012). HIF-1$\alpha$ contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression. Acta Med Okayama, 66, 399-407.
  6. Li DW, Zhou L, Jin B, et al (2013). Expression and significance of hypoxia-inducible factor-1$\alpha$ and survivin in laryngeal carcinoma tissue and cells. Otolaryngol Head Neck Surg, 148, 75-81.
  7. Li L, Jiang AC, Dong P, et al (2007). The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg, 137, 659-64.
  8. Liu L, Ning X, Sun L, et al (2008). Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci, 99, 121-8.
  9. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8.
  10. Li Y, Ye D (2010). Cancer therapy by targeting hypoxia-inducible factor-1. Curr Cancer Drug Targets, 10, 782-96.
  11. O'Donnell JL, Joyce MR, Shannon AM, et al (2006). Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treat Rev, 32, 407-16.
  12. Park SY, Jang WJ, Yi EY, et al (2010). Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res, 48, 178-84.
  13. Schrijvers ML, van der Laan BF, de Bock GH (2008). Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glotticlaryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys, 72, 161-9.
  14. Sowter HM, Raval RR, Moore JW (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res, 63, 6130-4.
  15. Tak E, Lee S, Lee J, et al (2011). Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. J Hepatol, 54, 328-39.
  16. Thews O, Nowak M, Sauvant C, Gekle M (2011). Hypoxia-induced extracellular acidosis increases p-glycoprotein activity and chemoresistance in tumors in vivo via p38 signaling pathway. Adv Exp Med Biol, 701, 115-22.
  17. Wang GL, Jiang BH, Rue EA, Semenza GL (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A, 92, 5510-4.
  18. Wohlkoenig C, Leithner K, Deutsch A, et al (2011). Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells. Cancer Lett, 308, 134-43.
  19. Wu XH, Lu YF, Hu XD, et al (2010). Expression of hypoxia inducible factor-1$\alpha$ and its significance in laryngeal carcinoma. J Int Med Res, 38, 2040-6.
  20. Yoshiba S, Ito D, Nagumo T, et al (2009). Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. Oral Oncol, 45, 109-15.
  21. Zhang L, Huang G, Li X, et al (2013). Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1$\alpha$ in hepatocellular carcinoma. BMC Cancer, 13, 108.
  22. Zhu H, Chen XP, Luo SF, et al (2005). Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res, 24, 565-74.

Cited by

  1. Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells vol.10, pp.6, 2014,
  2. Expression of Hypoxia-inducible Factor Prolyl Hydroxylase 3 HIFPH3 in Human Non-small Cell Lung Cancer (NSCLC) and Its Correlation with Prognosis vol.15, pp.14, 2014,
  3. Influence of Ionizing Radiation on Ovarian Carcinoma SKOV-3 Xenografts in Nude Mice under Hypoxic Conditions vol.15, pp.5, 2014,
  4. Glycididazole Sodium Combined with Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma vol.15, pp.6, 2014,
  5. Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines vol.31, pp.6, 2014,
  6. Liposome-Encapsulated Hemoglobin Enhances Chemotherapy to Suppress Metastasis in Mice vol.38, pp.8, 2014,
  7. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a vol.10, pp.8, 2015,
  8. 4-Hydroxynonenal Promotes Growth and Angiogenesis of Breast Cancer Cells through HIF-1α Stabilization vol.15, pp.23, 2015,
  9. Relative quantitative expression of hypoxia-inducible factor-1α, -2α and -3α, and vascular endothelial growth factor A in laryngeal carcinoma pp.1792-1082, 2015,
  10. Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1 pp.18047521, 2015,
  11. Natural Polyphenols in Cancer Chemoresistance vol.68, pp.6, 2016,
  12. Role of proton pumps in tumorigenesis vol.82, pp.4, 2017,
  13. Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells vol.12, pp.2, 2016,
  14. Effects of hypoxia inducible factor-1α on apoptotic inhibition and glucocorticoid receptor downregulation by dexamethasone in AtT-20 cells vol.15, pp.1, 2015,
  15. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape vol.18, pp.1, 2019,